Similar in vitro pharmacology of human cannabinoid CB1 receptor variants expressed in CHO cells

Brain Research

Volumn 1238, Issue , 2008, Pages 36-43

  Xiao, Jing Chen ^a   Jewell, James P ^a   Lin, Linus S ^a   Hagmann, William K ^a   Fong, Tung M ^a   Shen, Chun Pyn ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

CB 1 receptor inverse agonist; Endocannabinoid; Human cannabinoid CB1 receptor; Human cannabinoid CB1a receptor; Human cannabinoid CB1b receptor

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2 ARACHIDONOYLGLYCEROL; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; AMIDE; CANNABINOID 1 RECEPTOR; DOCOSATETRAENYLETHANOLAMIDE; ENDOCANNABINOID; METHANANDAMIDE; NOLADIN ETHER; UNCLASSIFIED DRUG; VIRODHAMINE;

ADULT; ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; DRUG RECEPTOR BINDING; FETUS; HUMAN; HUMAN TISSUE; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR AFFINITY;

ALTERNATIVE SPLICING; ANIMALS; BRAIN; CHO CELLS; CRICETINAE; CRICETULUS; HUMANS; POLYMERASE CHAIN REACTION; RECEPTOR, CANNABINOID, CB1; RNA, MESSENGER;

EID: 55349085391     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.08.027     Document Type: Article

References (30)

1. Bouaboula M., Poinot-Chazel C., Bourrie B., Canat X., Calandra B., Rinaldi-Carmona M., Le Fur G., and Casellas P. Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1 Biochem. J. 312 Pt 2 1995 637 641
2. Bouaboula M., Perrachon S., Milligan L., Canat X., Rinaldi-Carmona M., Portier M., Barth F., Calandra B., Pecceu F., Lupker J., Maffrand J.P., Le Fur G., and Casellas P. A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor/ligand interactions J. Biol. Chem. 272 35 1997 22330 22339
3. Croci T., Manara L., Aureggi G., Guagnini F., Rinaldi-Carmona M., Maffrand J.P., Le Fur G., Mukenge S., and Ferla G. In vitro functional evidence of neuronal cannabinoid CB1 receptors in human ileum Br. J. Pharmacol. 125 7 1998 1393 1395
4. D'Ambra T.E., Estep K.G., Bell M.R., Eissenstat M.A., Josef K.A., Ward S.J., Haycock D.A., Baizman E.R., Casiano F.M., and Beglin N.C. Conformationally restrained analogues of pravadoline: nanomolar potent, enantioselective, (aminoalkyl)indole agonists of the cannabinoid receptor J. Med. Chem. 35 1 1992 124 135
5. DeBlasi A., O'Reilly K., and Motulsky H.J. Calculating receptor number from binding experiments using same compound as radioligand and competitor Trends Pharmacol. Sci. 10 1989 227 229
6. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., and Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor Science 258 5090 1992 1946 1949
7. Di Marzo V., Goparaju S.K., Wang L., Liu J., Batkai S., Jarai Z., Fezza F., Miura G.I., Palmiter R.D., Sugiura T., and Kunos G. Leptin-regulated endocannabinoids are involved in maintaining food intake Nature 410 6830 2001 822 825
8. Gerard C.M., Mollereau C., Vassart G., and Parmentier M. Molecular cloning of a human cannabinoid receptor which is also expressed in testis Biochem. J. 279 Pt 1 1991 129 134
9. Hanus L., Gopher A., Almog S., and Mechoulam R. Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor J. Med. Chem. 36 20 1993 3032 3034
10. Hanus L., Abu-Lafi S., Fride E., Breuer A., Vogel Z., Shalev D.E., Kustanovich I., and Mechoulam R. 2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor Proc. Natl. Acad. Sci. U. S. A. 98 7 2001 3662 3665
11. Herkenham M., Lynn A.B., Little M.D., Johnson M.R., Melvin L.S., de Costa B.R., and Rice K.C. Cannabinoid receptor localization in brain Proc. Natl. Acad. Sci. U. S. A. 87 5 1990 1932 1936
12. Huffman J.W., Yu S., Showalter V., Abood M.E., Wiley J.L., Compton D.R., Martin B.R., Bramblett R.D., and Reggio P.H. Synthesis and pharmacology of a very potent cannabinoid lacking a phenolic hydroxyl with high affinity for the CB2 receptor J. Med. Chem. 39 20 1996 3875 3877
13. Ledent C., Valverde O., Cossu G., Petitet F., Aubert J.F., Beslot F., Bohme G.A., Imperato A., Pedrazzini T., Roques B.P., Vassart G., Fratta W., and Parmentier M. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice Science 283 5400 1999 401 404
14. Lin L.S., Lanza T.J. Jr., Jewell J.P., Liu P., Shah S.K., Qi H., Tong X., Wang J., Xu S.S., Fong T.M., Shen C.P., Lao J., Xiao J.C., Shearman L.P., Stribling D.S., Rosko K., Strack A., Marsh D.J., Feng Y., Kumar S., Samuel K., Yin W., Van der Ploeg L.H., Goulet M.T., and WK H. Discovery of N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl] -2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (MK-0364), a novel, acyclic cannabinoid-1 receptor inverse agonist for the treatment of obesity J. Med. Chem. 49 26 2006 7584 7587
15. Luk T., Jin W., Zvonok A., Lu D., Lin X.Z., Chavkin C., Makriyannis A., and Mackie K. Identification of a potent and highly efficacious, yet slowly desensitizing CB1 cannabinoid receptor agonist Br. J. Pharmacol. 142 3 2004 495 500
16. Mackie K., Lai Y., Westenbroek R., and Mitchell R. Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor J. Neurosci. 15 10 1995 6552 6561
17. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., and Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA Nature 346 6284 1990 561 564
18. Mechoulam R., Ben-Shabat S., Hanus L., Ligumsky M., Kaminski N.E., Schatz A.R., Gopher A., Almog S., Martin B.R., and Compton D.R. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors Biochem. Pharmacol. 50 1 1995 83 90
19. Melvin L.S., Milne G.M., Johnson M.R., Wilken G.H., and Howlett A.C. Structure-activity relationships defining the ACD-tricyclic cannabinoids: cannabinoid receptor binding and analgesic activity Drug Des. Discov. 13 2 1995 155 166
20. Pertwee R.G. Cannabinoids and the gastrointestinal tract Gut 48 6 2001 859 867
21. Porter A.C., Sauer J.M., Knierman M.D., Becker G.W., Berna M.J., Bao J., Nomikos G.G., Carter P., Bymaster F.P., Leese A.B., and Felder C.C. Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor J. Pharmacol. Exp. Ther. 301 3 2002 1020 1024
22. Rinaldi-Carmona M., Barth F., Heaulme M., Shire D., Calandra B., Congy C., Martinez S., Maruani J., Neliat G., and Caput D. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor FEBS. Lett. 350 2-3 1994 240 244
23. Rinaldi-Carmona M., Calandra B., Shire D., Bouaboula M., Oustric D., Barth F., Casellas P., Ferrara P., and Le Fur G. Characterization of two cloned human CB1 cannabinoid receptor isoforms J. Pharmacol. Exp. Ther. 278 2 1996 871 878
24. Ryberg E., Vu H.K., Larsson N., Groblewski T., Hjorth S., Elebring T., Sjogren S., and Greasley P.J. Identification and characterisation of a novel splice variant of the human CB1 receptor FEBS. Lett. 579 1 2005 259 264
25. Shire D., Carillon C., Kaghad M., Calandra B., Rinaldi-Carmona M., Le Fur G., Caput D., and Ferrara P. An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing J. Biol. Chem. 270 8 1995 3726 3731
26. Szabo B., Nordheim U., and Niederhoffer N. Effects of cannabinoids on sympathetic and parasympathetic neuroeffector transmission in the rabbit heart J. Pharmacol. Exp. Ther. 297 2 2001 819 826
27. Tsou K., Brown S., Sanudo-Pena M.C., Mackie K., and Walker J.M. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system Neuroscience 83 2 1998 393 411
28. Wagner J.A., Jarai Z., Batkai S., and Kunos G. Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors Eur. J. Pharmacol. 423 2-3 2001 203 210
29. Wang H., Guo Y., Wang D., Kingsley P.J., Marnett L.J., Das S.K., DuBois R.N., and Dey S.K. Aberrant cannabinoid signaling impairs oviductal transport of embryos Nat. Med. 10 10 2004 1074 1080
30. Zimmer A., Zimmer A.M., Hohmann A.G., Herkenham M., and Bonner T.I. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice Proc. Natl. Acad. Sci. U. S. A. 96 10 1999 5780 5785